Complete Filing Data
Haoxi Health Technology Ltd reported Stockholders Equity of $17.38 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Haoxi Health Technology Ltd did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income Loss | $3.9M | $1.3M | $969.8K | $244.6K |
| Revenues | $32.8M | $48.5M | $28.2M | $16.2M |
| Research And Development Expense | $79.5K | $80.0K | $58.2K | $102.5K |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$1.1K | $387.00 | $68.2K | $63.0K |
| Operating Income Loss | -$2.0M | $1.7M | $1.2M | $268.8K |
| Operating Expenses | $2.9M | $1.0M | $866.3K | $380.0K |
| Nonoperating Income Expense | $6.1M | $18.0K | -$5.4K | -$9.2K |
| Income Tax Expense Benefit | $270.7K | $443.6K | $220.7K | $15.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $4.1M | $1.7M | $1.2M | $259.6K |
| Gross Profit | $927.8K | $2.8M | $2.1M | $648.7K |
| General And Administrative Expense | $2.8M | $911.5K | $776.0K | $239.9K |
| Cost Of Revenue | $31.9M | $45.8M | $26.2M | $15.5M |
| Other Nonoperating Income Expense | -$12.5K | -$16.9K | $15.5K | $788.00 |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $387.00 | $68.2K | $63.0K | |
| Income Taxes Paid Net | $7.3K | $27.6K | $7.4K | |
| Comprehensive Income | $3.9M | $1.3M | $1.0M | |
| Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | -$1.1K | $387.00 | $68.2K | |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $1.3M | $1.0M | $307.6K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | $17.4M | $11.3M | $1.6M | -$1.5M | -$1.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $8.6M | $6.7M | $1.2M | $293.5K | $55.9K |
| Repayments Of Short Term Debt | $1.2M | $115.9K | $345.6K | $52.1K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $2.0M | $5.5M | $909.7K | $237.6K | |
| Taxes Payable Current | $1.3M | $1.0M | $328.1K | ||
| Retained Earnings Accumulated Deficit | $4.6M | $723.2K | -$568.5K | ||
| Property Plant And Equipment Net | $108.9K | $126.7K | $143.8K | ||
| Liabilities Noncurrent | $333.8K | $368.0K | $321.2K | ||
| Liabilities Current | $3.9M | $3.9M | $2.6M | ||
| Liabilities And Stockholders Equity | $21.6M | $15.5M | $4.5M | ||
| Liabilities | $4.2M | $4.2M | $2.9M | ||
| Employee Related Liabilities Current | $32.3K | $41.1K | $37.1K | ||
| Assets Noncurrent | $2.0M | $126.7K | $790.1K | ||
| Assets Current | $19.6M | $15.4M | $3.7M | ||
| Assets | $21.6M | $15.5M | $4.5M | ||
| Additional Paid In Capital Common Stock | $12.8M | $10.6M | $2.2M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$45.5K | -$44.4K | -$44.8K | ||
| Accounts Receivable Net Current | $460.3K | $226.7K | $7.7K | ||
| Accounts Payable Current | $153.9K | $653.7K | $27.3K | ||
| Accounts Payable And Other Accrued Liabilities Current | $102.4K | $41.5K | |||
| Prepaid Expense And Other Assets Current | $4.8M | $3.3M | $58.5K | ||
| Long Term Loans Payable | $26.5K | $66.4K | |||
| Contract With Customer Liability Current | $537.6K | $1.2M | |||
| Other Long Term Debt Noncurrent | $307.3K | $301.7K | |||
| Operating Lease Right Of Use Asset | $79.2K | $89.5K | |||
| Operating Lease Liability Current | $79.2K | $89.5K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Proceeds From Short Term Debt | $2.0M | $478.4K | $453.1K | $329.9K |
| Net Cash Provided By Used In Operating Activities | -$3.4M | -$747.6K | -$872.1K | -$675.4K |
| Net Cash Provided By Used In Investing Activities | -$3.6M | -$3.1M | -$45.5K | -$8.7K |
| Net Cash Provided By Used In Financing Activities | $8.9M | $9.3M | $1.8M | $933.2K |
| Increase Decrease In Prepaid Supplies | $548.6K | $2.7M | $2.5M | -$439.4K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $777.00 | $175.3K | -$51.9K | -$8.1K |
| Increase Decrease In Operating Lease Liability | -$77.1K | $90.4K | $29.4K | -$87.7K |
| Increase Decrease In Employee Related Liabilities | -$2.0K | $3.4K | $16.1K | -$4.1K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$104.5K | $60.1K | $14.4K | -$31.6K |
| Increase Decrease In Accrued Income Taxes Payable | $267.3K | $708.7K | $330.3K | -$29.0K |
| Increase Decrease In Accounts Receivable | $254.0K | $217.9K | $4.3K | -$665.6K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$1.7K | $5.6K | $24.8K | -$11.5K |
| Payments To Acquire Property Plant And Equipment | $55.4K | $45.5K | $8.7K | |
| Increase Decrease In Other Operating Assets | $90.4K | $7.6K | -$90.4K | |
| Proceeds From Repayments Of Related Party Debt | -$14.3K | $21.0K | -$811.3K | |
| Proceeds From Issuance Of Common Stock | $9.0M | $2.0M | $163.9K | |
| Increase Decrease In Contract With Customer Liability | -$642.1K | -$328.1K | $1.4M | |
| Increase Decrease In Accounts Payable | $623.2K | -$1.2M | -$1.6M | |
| Payments To Fund Longterm Loans To Related Parties | $2.5M | $3.1M | ||
| Payments Of Financing Costs | $2.8M | $579.6K | ||
| Proceeds From Related Party Debt | $1.3M | |||
| Increase Decrease In Customer Advances | -$328.1K | $1.4M | -$369.2K | |
| Increase Decrease In Accounts Payable Trade | -$496.8K | $623.2K | -$1.2M | |
| Share Based Compensation | $58.6K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 2.3M | 1.2M | 1.1M | 25.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 2.4M | 1.2M | 1.1M | 25.0M |
| Earnings Per Share Diluted | $1.32 | $1.06 | $0.87 | $0.01 |
| Earnings Per Share Basic | $1.66 | $1.06 | $0.87 | $0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Selling Expense | $50.2K | $41.6K | $32.1K | $37.5K |
| Interest Paid Net | $43.3K | $37.3K | $19.8K | $206.00 |
| Depreciation | $294.6K | $10.6K | $8.4K | $2.2K |
| Investment Income Investment Expense | $46.0K | $41.2K | $20.9K | $10.0K |
| Supplies | $5.7M | $5.2M | $2.4M | |
| Stock Issued During Period Value New Issues | $1.3M | $10.6M | ||
| Short Term Borrowings | $1.3M | $833.5K | $511.4K | |
| Operating Right Of Use Asset | $89.5K | $88.5K | ||
| Investment Income Interest | $363.3K | $76.1K |
Most recent annual filing with the SEC: October 20, 2025
Data sourced from SEC EDGAR public filings as of August 8, 2026.